We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$11.2B
AUM Growth
+$4.26B
(+61%)
Cap. Flow
+$3.37B
Cap. Flow
% of AUM
30.06%
Top 10 Holdings %
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294
Avg Time Held Equity + Options
1.3
quarters
Top 10 Avg Time Held Equity + Options
0.9
quarters
Top 20 Avg Time Held Equity + Options
0.9
quarters
Avg Time Held Equity only
1.2
quarters
Top 10 Avg Time Held Equity only
0.9
quarters
Top 20 Avg Time Held Equity only
0.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
+$645M |
| 2 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$539M |
| 3 |
MXIM
Maxim Integrated Products
MXIM
|
+$525M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$520M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$475M |
| 2 |
RP
RealPage, Inc.
RP
|
+$281M |
| 3 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$209M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$170M |
| 5 |
CLGX
Corelogic, Inc.
CLGX
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.69% |
| 2 | Healthcare | 19.01% |
| 3 | Financials | 14.31% |
| 4 | Real Estate | 10.94% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Arbor Realty Trust
ABR
$535M
| $4M | 0.04% |
224,325
+36,125
| +19% | +$635K |
2020 Q3
3 quarters
|
|
|
EMBK
302
DELISTED
Embark Technology, Inc. Common Stock
EMBK
| $3.99M | 0.04% |
20,068
+7,568
| +61% | +$1.51M |
2021 Q1
1 quarter
|
|
|
CTAQ
303
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
| $3.98M | 0.04% |
410,707
| – | – |
2021 Q1
1 quarter
|
|
304
DELISTED
Waldencast
WALD
| $3.98M | 0.04% |
+400,261
| New | +$3.96M |
2021 Q2
0 quarters
|
|
305
Fidelity National Information Services
FIS
$17.6B
| $3.97M | 0.04% |
+28,000
| New | +$4.16M |
2021 Q2
0 quarters
|
|
|
QNGY
306
DELISTED
Quanergy Systems, Inc.
QNGY
| $3.96M | 0.04% |
19,980
-5,019
| -20% | -$1,000K |
2020 Q2
4 quarters
|
|
307
P3 Health Partners
PIII
$19.4M
| $3.95M | 0.04% |
+7,992
| New | +$3.92M |
2021 Q2
0 quarters
|
|
|
REVH
308
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
| $3.93M | 0.04% |
+400,392
| New | +$3.94M |
2021 Q2
0 quarters
|
|
309
DELISTED
Core Scientific, Inc. Common Stock
CORZ
| $3.92M | 0.04% |
+399,195
| New | +$3.93M |
2021 Q2
0 quarters
|
|
|
FRXB
310
DELISTED
Forest Road Acquisition Corp. II
FRXB
| $3.92M | 0.04% |
+400,261
| New | +$3.92M |
2021 Q2
0 quarters
|
|
|
HZON
311
DELISTED
Horizon Acquisition Corporation II
HZON
| $3.92M | 0.04% |
401,566
-200,783
| -33% | -$2.01M |
2020 Q4
2 quarters
|
|
|
PRPC
312
DELISTED
CC Neuberger Principal Holdings III
PRPC
| $3.91M | 0.03% |
+399,985
| New | +$3.95M |
2021 Q2
0 quarters
|
|
|
FMIV
313
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
| $3.91M | 0.03% |
+400,196
| New | +$3.91M |
2021 Q2
0 quarters
|
|
|
NDAC
314
DELISTED
NightDragon Acquisition Corp. Class A Common stock
NDAC
| $3.91M | 0.03% |
+400,261
| New | +$3.93M |
2021 Q2
0 quarters
|
|
|
CFV
315
DELISTED
CF Acquisition Corp. V Class A Common Stock
CFV
| $3.9M | 0.03% |
399,985
| – | – |
2021 Q1
1 quarter
|
|
|
ATAQ
316
DELISTED
Altimar Acquisition Corp III
ATAQ
| $3.9M | 0.03% |
+400,261
| New | +$3.94M |
2021 Q2
0 quarters
|
|
317
Redwire
RDW
$2.39B
| $3.9M | 0.03% |
378,308
-95,572
| -20% | -$970K |
2021 Q1
1 quarter
|
|
|
DHBC
318
DELISTED
DHB Capital Corp. Class A common stock
DHBC
| $3.9M | 0.03% |
+399,935
| New | +$3.89M |
2021 Q2
0 quarters
|
|
|
FSRD
319
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
| $3.89M | 0.03% |
+399,195
| New | +$3.93M |
2021 Q2
0 quarters
|
|
|
MBAC
320
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
| $3.89M | 0.03% |
+400,261
| New | +$3.9M |
2021 Q2
0 quarters
|
|
|
VEEA
321
Veea Inc
VEEA
$17.7M
| $3.89M | 0.03% |
+20,013
| New | +$3.92M |
2021 Q2
0 quarters
|
|
|
KAIR
322
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
| $3.88M | 0.03% |
399,591
-100,391
| -20% | -$979K |
2021 Q1
1 quarter
|
|
|
AEAC
323
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
| $3.87M | 0.03% |
399,591
-100,391
| -20% | -$975K |
2021 Q1
1 quarter
|
|
|
SBII
324
DELISTED
Sandbridge X2 Corp.
SBII
| $3.87M | 0.03% |
+400,261
| New | +$3.91M |
2021 Q2
0 quarters
|
|
|
PPGH
325
DELISTED
Poema Global Holdings Corp. Class A Ordinary Share
PPGH
| $3.87M | 0.03% |
399,591
-100,391
| -20% | -$978K |
2021 Q1
1 quarter
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q2 2021 Portfolio in Review
As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
UBS O'Connor deployed $3.37B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.
- UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
- UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
- UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
- UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
- UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
- UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
- UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.
Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.